Overview
Sean Vance is a Radiation Oncologist in Detroit, Michigan. Dr. Vance is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Laryngeal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Vance is currently accepting new patients.
His clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
Locations
2799 W Grand Blvd, Detroit, MI 48202
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Henry Ford Health System
Aharon Feldman is a Radiation Oncologist in Detroit, Michigan. Dr. Feldman has been practicing medicine for over 9 years and is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Protein Deficiency, Prostate Cancer, Familial Prostate Cancer, and Seasonal Affective Disorder (SAD). Dr. Feldman is currently accepting new patients.
Beaumont Medical Group- Specialty Services
Zachary Seymour is a Radiation Oncologist in Royal Oak, Michigan. Dr. Seymour has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Prostate Cancer, Metastatic Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Hormone Replacement Therapy (HRT). Dr. Seymour is currently accepting new patients.
Beaumont Medical Group- Specialty Services
Thomas Quinn is a Radiation Oncologist in Royal Oak, Michigan. Dr. Quinn is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Anal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Tumor. Dr. Quinn is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Laryngeal CancerDr. Vance isDistinguished. Learn about Laryngeal Cancer.
- Lung CancerDr. Vance isDistinguished. Learn about Lung Cancer.
- Advanced
- AstrocytomaDr. Vance isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Embryonal Tumor with Multilayered Rosettes
- Familial Prostate CancerDr. Vance isAdvanced. Learn about Familial Prostate Cancer.
- GliosarcomaDr. Vance isAdvanced. Learn about Gliosarcoma.
- Hodgkin LymphomaDr. Vance isAdvanced. Learn about Hodgkin Lymphoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Vance isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Vance isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Vance isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Vance isExperienced. Learn about Angiosarcoma.